Herpes simplex virus-1 and varicella-zoster virus latency in ganglia
- 176 Downloads
Two human alpha-herpesviruses, herpes simplex virus (HSV)-1 and varicella zoster virus (VZV), account for the most frequent and serious neurologic disease caused by any of the eight human herpesviruses. Both HSV-1 and VZV become latent in ganglia. In this review, the authors describe features of latency for these viruses, such as distribution, prevalence, abundance, and configuration of viral DNA in latently infected human ganglia, as well as transcription, translation, and cell type infected. Studies of viral latency in animal models are also discussed. For each virus, remaining questions and future studies to understand the mechanism of latency are discussed with respect to prevention of serious cutaneous, ocular, and neurologic disease produced by virus reactivation.
KeywordsHSV latency VZV
Unable to display preview. Download preview PDF.
- Cohrs RJ, Srock K, Barbour MB, Owens G, Mahalingam R, Devlin ME, Wellish M, Gilden DH (1994). Varicellazoster virus (VZV) transcription during latency in human ganglia: construction of a cDNA library from latently infected human trigeminal ganglia and detection of a VZV transcript. J Virol 68: 7900–7908.PubMedGoogle Scholar
- de Jong MD, Weel JF, Schuurman T, Wertheim-van Dillen PM, Boom R (2000). Quantitation of varicella-zoster virus DNA in whole blood, plasma, and serum by PCR and electrochemiluminescence. JClin Microbiol 38: 2568–2573.Google Scholar
- Devi-Rao GB, Bloom DC, Stevens JG, Wagner EK (1994). Herpes simplex virus type 1 DNA replication and gene expression during explant induced reactivation of latently infected murine sensory ganglia. J Virol 68: 12 71—1282.Google Scholar
- Hill JM, Dudley JB, Shimomura Y, Kaufman HE (1986). Quantitation and kinetics of induced HSV-1 ocular shedding. CurrEye Res 5: 241–246.Google Scholar
- Koskiniemi M, Rantalaiho T, Piiparinen H, von Bonsdorff CH, Farkkila M, Jarvinen A, Kinnunen E, Koskiniemi S, Mannonen L, Muttilainen M, Linnavuori K, Porras J, Puolakkainen M, Raiha K, Salonen EM, Ukkonen P, Vaheri A, Valtonen V (2001). Infections of the central nervous system of suspected viral origin: a collaborative study from Finland. J NeuroVirol 7: 400–408.PubMedCrossRefGoogle Scholar
- Perng GC, Maguen B, Jin L, Mott KR, Kurylo J, BenMohamed L, Yukht A, Osorio N, Nesburn AB, Henderson G, Inman M, Jones C, Wechsler SL (2002). A novel herpes simplex virus type 1 transcript (AL-RNA) antisense to thje 5′ end of the latency associated transcript produces a protein in infected rabbits. J Virol 76: 8003–8010.PubMedCrossRefGoogle Scholar
- Preston VG, Kennard J, Rixon FJ, Logan AJ, Mansfield RW, McDougall IM (1997). Efficient herpes simplex virus type 1 (HSV-1) capsid formation directed by the varicella-zoster virus scaffolding protein requires the carboxy-terminal sequences from the HSV-1 homologue. J Gen Virol 78: 1633–1646.PubMedGoogle Scholar
- Roizman B, Knipe DM (2001). Herpes simplex viruses and their replication. In: Fields virology, 4th ed, vol 2. Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (eds). Philadephia: Lippincott-Raven, pp 2399–2460.Google Scholar
- Thomas SK, Lilley CE, Latchman DS, Coffin RS (2002). A protein encoded by the herpes simplex virus (HSV) type 1 2-kilobase latency-associated transcript is phosphorylated, localized to the nucleus, and overcomes the repression of expression from exogenous promoters when inserted into the quiescent HSV genome. J Virol 76: 4056–4067.PubMedCrossRefGoogle Scholar
- Warren KG, Devlin M, Gilden DH, Wroblewska Z, Koprowski H, Brown SM, Subak-Sharpe J (1978). Herpes simplex virus latency in patients with multiple sclerosis, lymphoma and normal humans. In: Oncogenesis and herpesvirus III, part 2: Cell-virus interactions, host response to herpesvirus infection and associated tumors, role of co-factors. de-The G, Henle W, Rapp R. (eds.). International agency for research on cancer, Lyon, France, pp. 765–768.Google Scholar